Retour
Prix BioAdaptives Inc (BDPT)
Graphique du cours de l'action BDPT
BDPT Gagner
BioAdaptives Inc
$0.01
-19.09%
$0
À partir d'aujourd'hui :Feb 12, 12:50:42 GMT-5
Pas encore de donnéesEarnings FAQ
Comment le bénéfice par action récent de BDPT se compare-t-il aux attentes ?
Comment les revenus de BioAdaptives Inc BDPT se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour BioAdaptives Inc ?
Quel est le score de qualité des bénéfices pour BioAdaptives Inc ?
Quand BioAdaptives Inc publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de BioAdaptives Inc ?
BioAdaptives Inc a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$0.0199
Prix d'ouverture
$0.0161
Plage de la journée
$0.0161 - $0.0161
Plage de 52 semaines
$0.0131 - $0.12
Volume
275
Volume moyen
31.7K
BPA (TTM)
-0.09
Rendement en dividend
--
Capitalisation boursière
$193.3K
Qu’est-ce que BDPT ?
BioAdaptives, Inc. engages in marketing, investigating, and distributing natural plant and algal-based products that improve health and wellness for humans and animals. The company is headquartered in Las Vegas, Nevada and currently employs 1 full-time employees. The company went IPO on 2014-07-09. The Company’s core business is to investigate, market and distribute natural plant, fungi, and algal based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products in development include a weight management supplement in a human clinical trial, Zeranovia. Zeranovia is made of natural ingredients and uses proprietary methods of optimizing the availability of nutrients in foods and beverages. Xcellara regenerative stem cell activator is in production. Xcellara is its regenerative wellness solution, to enhance performance, accelerate recovery, and revitalize health. PawPa Regen is the canine treat stem cell activator. PawPa Regen supports anti-aging and wellness. Its other products include MyndMed and Wynovia. MyndMed is designed to optimize multiple neurotransmitter systems and neuroprotective pathways.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.